| Perillyl alcohol for the treatment of temozolomide-resistant gliomas HY Cho, W Wang, N Jhaveri, S Torres, J Tseng, MN Leong, DJ Lee, ... Molecular cancer therapeutics 11 (11), 2462-2472, 2012 | 104 | 2012 |
| NEO212, temozolomide conjugated to perillyl alcohol, is a novel drug for effective treatment of a broad range of temozolomide-resistant gliomas HY Cho, W Wang, N Jhaveri, DJ Lee, N Sharma, L Dubeau, AH Schönthal, ... Molecular cancer therapeutics 13 (8), 2004-2017, 2014 | 65 | 2014 |
| Mechanisms driving immune-related adverse events in cancer patients treated with immune checkpoint inhibitors DJ Lee, HJ Lee, JR Farmer, KL Reynolds Current Cardiology Reports 23, 1-12, 2021 | 61 | 2021 |
| Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study H El-Khoury, DJ Lee, JB Alberge, R Redd, CJ Cea-Curry, J Perry, H Barr, ... The Lancet Haematology 9 (5), e340-e349, 2022 | 45 | 2022 |
| Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study A Cowan, F Ferrari, SS Freeman, R Redd, H El-Khoury, J Perry, V Patel, ... The Lancet Haematology 10 (3), e203-e212, 2023 | 34 | 2023 |
| Extreme body mass index and survival in newly diagnosed multiple myeloma patients UA Shah, K Whiting, S Devlin, R Ershler, B Kanapuru, DJ Lee, S Tahri, ... Blood Cancer Journal 13 (1), 13, 2023 | 9 | 2023 |
| Mass spectrometry-detected MGUS is associated with obesity and other novel modifiable risk factors in a high-risk population DJ Lee, H El-Khoury, AC Tramontano, JB Alberge, J Perry, MI Davis, ... Blood Advances 8 (7), 1737-1746, 2024 | 8 | 2024 |
| Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: A prospective cohort study H El-Khoury, DJ Lee, JB Alberge, R Redd, CJ Cea-Curry, J Perry, H Barr, ... | 6 | 2021 |
| Design and Rationale of Prolonged Nightly Fasting for Multiple Myeloma Prevention (PROFAST): Protocol for a Randomized Controlled Pilot Trial DJ Lee, EK O'Donnell, N Raje, C Panaroni, R Redd, J Ligibel, DD Sears, ... JMIR Research Protocols 13 (1), e51368, 2024 | 2 | 2024 |
| Prevalence of Monoclonal Gammopathies Including an Age-Related Monoclonal Gammopathy of Indeterminate Potential (MGIP) in a Racially Diverse US Population Screened by Mass … H El-Khoury, DJ Lee, JB Alberge, R Redd, CJ Cea-Curry, J Perry, H Barr, ... | 2 | 2022 |
| Persistence of Monoclonal Gammopathies in Serial Samples from a US Population-Based Screening Study H El-Khoury, L Bertamini, JB Alberge, DJ Lee, C Murphy, G Fleming, ... Blood 140 (Supplement 1), 10101-10103, 2022 | 1 | 2022 |
| Abnormal free light chains in individuals with African ancestry screened for monoclonal gammopathy: definition of new reference range accounting for renal function and race L Bertamini, JB Alberge, H El-Khoury, DJ Lee, C Murphy, G Fleming, ... Blood 140 (Supplement 1), 10005-10006, 2022 | 1 | 2022 |
| P-092 High serum free light chains levels in African ancestry population screened for monoclonal gammopathy: implication for definition of FLC reference range accounting for … L Bertamini, JB Alberge, H El-Khoury, D Lee, G Fleming, C Murphy, ... Clinical Lymphoma Myeloma and Leukemia 23, S85, 2023 | | 2023 |
| Prevalence of Monoclonal Gammopathies Detected By Mass Spectrometry and Their Risk Factors Among Black Africans in South Africa DJ Lee, H El-Khoury, L Bertamini, JB Alberge, MI Davis, J Perry, ... Blood 140 (Supplement 1), 7228-7229, 2022 | | 2022 |
| OAB-036: The PANGEA model: dynamic modeling for personalized prediction of precursor disease progression to multiple myeloma A Cowan, F Ferrari, S Freeman, R Redd, H El-Khoury, J Perry, V Patel, ... Clinical Lymphoma Myeloma and Leukemia 22, S21-S22, 2022 | | 2022 |
| Obesity, metabolic comorbidities, and lifestyle factors and their association with monoclonal gammopathies in a high-risk screened population: Results of the PROMISE study DJ Lee, H El-Khoury, JB Alberge, DJ Sakrikar, D Barnidge, MC Perkins, ... Cancer Research 82 (12_Supplement), 3651-3651, 2022 | | 2022 |
| Predictive modeling of smoldering multiple myeloma progression to multiple myeloma by continuous variable analysis A Cowan, H El-Khoury, F Ferrari, SS Freeman, R Redd, J Perry, V Patel, ... Cancer Research 82 (12_Supplement), 2259-2259, 2022 | | 2022 |
| Rapid, Point-of-Care Diagnosis of Tuberculosis With Novel Truenat Assay: Cost-Effectiveness and Budgetary Impact Analysis for India’s Public Sector DJ Lee | | 2019 |
| Mass Spectrometry-Detected Monoclonal Gammopathy of Undetermined Significance is Associated with Obesity and Other Novel Modifiable Risk Factors: Results of the Promise Study DJ Lee, H El-Khoury, AC Tramontano, JB Alberge, J Perry, MI Davis, ... | | |
| Meralgia Paresthetica in Patients with Obesity DJ Lee | | |
